Sunshine, Sea, and Season of Birth: MS Incidence in Wales by Gareth, Noble
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in :
PLOS ONE
                                
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa29587
_____________________________________________________________
 
Paper:
Balbuena, L., Middleton, R., Tuite-Dalton, K., Pouliou, T., Williams, K. & Noble, G. (2016).  Sunshine, Sea, and
Season of Birth: MS Incidence in Wales. PLOS ONE, 11(5), e0155181
http://dx.doi.org/10.1371/journal.pone.0155181
 
 
 
 
 
 
 
 
_____________________________________________________________
  
This article is brought to you by Swansea University. Any person downloading material is agreeing to abide by the
terms of the repository licence. Authors are personally responsible for adhering to publisher restrictions or conditions.
When uploading content they are required to comply with their publisher agreement and the SHERPA RoMEO
database to judge whether or not it is copyright safe to add this version of the paper to this repository. 
http://www.swansea.ac.uk/iss/researchsupport/cronfa-support/ 
 RESEARCH ARTICLE
Sunshine, Sea, and Season of Birth: MS
Incidence in Wales
Lloyd D. Balbuena¤a*, Rod M. Middleton, Katie Tuite-Dalton, Theodora Pouliou, Kate
Elizabeth Williams¤b, Gareth J. Noble
Swansea University Medical School, Swansea, Wales, United Kingdom
¤a Current address: Department of Psychiatry University of Saskatchewan, Saskatoon, Canada
¤b Current address: School of Psychology, University of Wales Trinity Saint David, Wales, United Kingdom
* lloyd.balbuena@usask.ca
Abstract
Maternal sun exposure in gestation and throughout the lifetime is necessary for vitamin D
synthesis, and living near the sea is a population level index of seafood consumption. The
aim of this study was to estimate the incidence rate of multiple sclerosis (MS) in Wales and
examine its association with sun exposure, coastal living, and latitude. The study used a
database of MS hospital visits and admissions in Wales between 2002 and 2013. For the
1,909 lower layer super output areas (LSOAs) in Wales, coastal status, population, longi-
tude/latitude, and average sunshine hours per day were obtained. Age-specific and age-
standardised MS incidence were calculated and modelled using Poisson regression. The
distribution of births by month was compared between MS cases and the combined
England andWales population. There were 3,557 new MS cases between 2002 and 2013,
with an average annual incidence of 8.14 (95% CI: 7.69–8.59) among males and 12.97
(95% CI: 12.44–13.50) among females per 100,000 population. The female-to-male ratio
was 1.86:1. For both sexes combined, the average annual incidence rate was 9.10 (95%
CI: 8.80–9.40). All figures are age-standardized to the 1976 European standard population.
Compared to the combined England and Wales population, more people with MS were born
in April, observed-to-expected ratio: 1.21 (95% CI: 1.08–1.36). MS incidence varied directly
with latitude and inversely with sunshine hours. Proximity to the coast was associated with
lower MS incidence only in easterly areas. This study shows that MS incidence rate in
Wales is comparable to the rate in Scotland and is associated with environmental factors
that probably represent levels of vitamin D.
Introduction
Several non-genetic factors including Epstein-Barr virus, insufficient sun exposure, and smok-
ing are reported to increase the risk for multiple sclerosis [1]. With the UK having one of the
highest prevalence rates for MS in Europe, [2]it is important to refine and update the incidence
rate of this degenerative disease. Scotland has a prevalence rate (255 per 105)[2]that is higher
than the rates both in England (199.9 per 105) and Wales (168 per 105)[3]. Relatively few
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Data Availability Statement: A minimal dataset
containing geographical information (LSOA, long-lats,
population counts broken down by age group, sex,
and year, sunshine levels, coastal indicator) is
included as a supplementary file. Individual-level data
for MS patients is accessible by applying to the SAIL
Databank (http://www.saildatabank.com/) after
approval by the Swansea University Institutional
Ethics Board for researchers who meet the criteria for
access to confidential data. Researchers who require
access to the data may contact Ms.Cynthia
McNerney (c.l.mcnerney@swansea.ac.uk),
Information Governance Coordinator) in the first
studies reported age- and sex-specific incidence rates [3, 4]and we are unaware of a study cov-
ering the entire Welsh nation.
It is theorised that the variation in MS prevalence by geography is due to environmental fac-
tors acting on genetic predispositions [5]. Vitamin D obtained from sunlight and the diet is
converted by the body into the metabolite 1,25-dyhydroxyvitamin D which activates the vita-
min D receptor (VDR) in cells [6]. In the brain, 1,25-dihydroxyvitamin D has direct and indi-
rect effects on T-cell lymphocytes, modulating the immune system’s inflammatory response
[7].With sufficient vitamin D, the balance between T-helper lymphocytes type 1 and type 2 is
stabilized. By contrast, vitamin D deficiency is associated with having more disease-causing T-
cells at the expense of regulatory cells [8]. This process is shared with other autoimmune dis-
eases such as rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, and lupus
erythematosus [9, 10].
Although the effects of sun exposure, latitude and month of birth overlap, month of birth is
an index of vitamin D availability in gestation [11]while latitude probably reflects life-long
exposure to UV radiation [12]. Sun exposure is the primary source of vitamin D synthesis in
humans and its relevance to MS is well-studied. The critical periods for sunshine exposure
have been variously reported as infancy and early years [12]to the entire childhood and adoles-
cence [13]. Immigration from a low to a high risk area before age 15 (but not after) was associ-
ated with higher MS risk [14].
According to a systematic review, 16 studies found an excess of MS births in April or spring.
In England and Scotland, MS births were higher in April or May than in the rest of the year,
compared to the general population [10]. With vitamin D deficiency as the hypothesized cause
of higher MS birth rates in spring, it is surprising that no association of 25OHD levels and risk
of multiple sclerosis was found [15]. Using a Mendelian randomization method, Mokry and
colleagues [16]reported that alleles associated with decreased 25OHD increased the odds of
MS, indicating that vitamin D insufficiency is probably a causal agent for MS. Overall, the pre-
ponderance of evidence, a dose-response relationship, and biological plausibility all support a
causal interpretation [6].
The correlation of MS prevalence with latitude is well-replicated. Studies from the US,
Japan, and Australia/New Zealand reported that greater distance from the equator correlated
with higher numbers of cases [17, 18]. The most striking effect is seen in temperate Tasmania
where MS prevalence is seven times higher than in tropical northern Queensland [19]. By con-
trast, the “latitude gradient” was not observed in Norway and in France [20] and a SW-NE gra-
dient was reported in the latter [21]. Latitude probably reflects levels of UV and vitamin D. It
could however be confounded by the genetic similarity of people living in the same place [3].
One way of teasing apart genes and environment is by accounting for the distribution of the
HLA-DRB1 allelle (the main genetic component for MS) when mapping MS prevalence by lati-
tude. Simpson and colleagues reported that the association of MS with latitude persists after
controlling for HLA-DRB1[22].
The influence of dietary vitamin D insufficiency or supplementation on MS is less widely
studied. Circumstantial evidence from Norway showed a lower incidence of MS in coastal fish-
ing areas as compared with inland areas [23]. It is proposed that a diet rich in fatty seafood aug-
ments UV levels [20]in the winter. However, seafood and dietary sources are not deemed
adequate to meet the optimal 25OHD serum level of 75 nmol/l level [24]. A review of clinical
trials reported that high-dose vitamin D supplementation was not associated with a decreased
relapse rate for MS patients [25].
Our objectives in this study were to estimate age and sex specific incidence of MS in Wales
and to assess its relation with sunshine hours, latitude, living by the coast, and month of birth.
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Materials and Methods
Data sources
The data for this project were collated from various sources. Data on MS episodes came from
the Secure Anonymised Information Linkage (SAIL) Databank, an electronic repository of
health data hosted by Swansea University [26, 27]. SAIL aims to take advantage of routinely
collected person-level electronic data for health and social research. SAIL was queried for per-
sons having an ICD code of 340 or G35x (MS) during the period 2002 to 2013. Using ICD
codes for case ascertainment has a sensitivity between 85–92.4 and a specificity between 55.9–
92.6 [28]. The Patient Episode Database for Wales (PEDW) database in SAIL has 100 percent
coverage of inpatient and outpatient (daycase) hospital visits in Wales. Since the UK clinical
guidelines of 2003 [29]have required that MS diagnosis be made by a specialist neurologist on
the basis of lesions, the PEDW is a trustworthy source of confirmed MS cases. PEDW does
not capture MS cases diagnosed in primary care. PEDW has individual-level data, obscuring
the values of certain variables (e.g. date of birth becomes week of birth) for confidentiality.
Each person has a unique identifier (called an “anonymous linking field”) which matches
one-to-one with a valid NHS number [30]. We extracted from PEDW the gender, week of
birth, and Lower Layer Super Output Area of residence (LSOA) of patients with MS. In the
UK, an LSOA is a geographic area with a mean population of 1,500. There are 1,909 LSOAs in
Wales.
Mid-year population estimates from 2002 to 2013 for all LSOAs in Wales were downloaded
from the Small Area Population Estimates of the ONS website. We summed these age-and
-gender-specific mid-year estimates in order to estimate the person-years contributed by each
LSOA. This served as our denominator for calculating incidence rate.
The UK Office of National Statistics (ONS) also has a list of LSOAs designated as coastal
communities (n = 422, for Wales). Accordingly, we coded all LSOAs in this list as “1” and the
rest as “0”. There were LSOAs that changed (either merged or split) between the UK Census
2001 and 2011 so we harmonized the codes using a cross-reference file provided by the ONS.
For sunshine levels, we used the 30-year average sunshine hours per day at each LSOA for
the period 1961 to 1990. The Met Office does not provide sunshine levels for each LSOA.
Instead, the Met Office divides UK land area into 440 grid boxes, each measuring 25 square
kilometres [31]. The method for constructing these grids is described elsewhere [32]. These
grid boxes are associated with rotated longitude/latitude values which we translated into real
longitude/latitude using a reference table at this web page: http://ukclimateprojections-ui.
metoffice.gov.uk/ui/docs/grids/prob_land_25km_rotated/index.php. Also, ONS has a file that
indicates the population centroids (in longitude/latitude) for each LSOA. We then matched
each population-weighted LSOA to the appropriate grid box based on the shortest haversine
distance. Unlike Euclidean distance, haversine takes into account the earth’s curvature. In sum-
mary, the MET Office provided sunshine hours for grid boxes which we matched to LSOAs
provided by the ONS using the longitude/latitude as the merge field.
Statistical Analysis
We calculated age-standardized incidence by first creating five-year age groups and dividing
the number of cases by the corresponding person-years in each LSOA. We collapsed the first
two groups (0 to 10 years) due to small numbers of cases. Age-specific estimates were calcu-
lated separately for males and females. We finally standardized these rates to the 1976 Euro-
pean standard population. Age-standardization allows for the comparison of rates where the
age structure of populations are not the same.
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To examine whether MS is seasonal by birth, we compared the number of MS patients born
in any given month with their counterparts in the general population of England and Wales.
Because month of birth was not tallied separately by the UK Office of National Statistics (ONS)
until the 1960s, we had to use combined figures for both nations. Furthermore, the ONS only
started recording month of birth from 1938. As a result, our month of birth analysis was
restricted to 2,927 MS patients (82 percent) who were born since 1938. We performed chi-
square tests to test whether the pattern of MS births resembled the general population. To keep
the family-wise error rate at .05, we required that each month’s chi-squared result be significant
at an alpha of .004.
We examined the influence of the environment by aggregating MS cases per LSOA (if any)
over the study period. This was our dependent variable. Our substantive predictors were hours
of sunshine per day, latitude, longitude, and whether the LSOA was a coastal city. For ease of
interpretation, we centred latitudes on Aberystwyth (latitude = 52.42) in the north/south
dimension. We also centred longitudes on Carmarthenshire (longitude = -4.26) in the east/
west dimension. Mid-year population estimates were used as an offset term in order to relate
the number of MS cases per LSOA with its mid-year population for each year. We explored
various interactions among predictors and used the pseudo-R squared statistic as a criterion
for selecting the best model.
Results
From 2002 to 2013, there were 1,256 new MS cases among men and 2,301 new cases among
women. The average annual incidence rate per 100,000 people was 8.14 (95% CI: 7.69–8.59)
for males and 12.97 (12.44–13.50) for females, for a sex ratio of 1.86:1 (female: male). For the
total population, the combined average incidence rate was 9.10 (8.80–9.40) (Table 1).These
Table 1. Average Annual Incidence of Multiple Sclerosis in Wales, by Sex and Age Group, from 2002 to 2013.
Males Females Combined
Age
Group
New
Cases
Person-
Years
Age-speciﬁc
rate**
New
Cases
Person-
Years
Age-speciﬁc
rate**
New
Cases
Person-
Years
Age-speciﬁc
rate**
0 to 9 9 2,092,636 0.43 8 1,985,087 0.4 17 4,077,723 0.42
10–14 19 1,139,767 1.67 11 1,083,276 1.02 30 2,223,043 1.35
15–19 25 1,209,624 2.07 26 1,155,986 2.25 51 2,365,610 2.16
20–24 32 1,208,228 2.65 60 1,177,370 5.1 92 2,385,598 3.86
25–29 46 1,052,498 4.37 117 1,045,740 11.19 163 2,098,238 7.77
30–34 75 1,056,610 7.1 158 1,084,615 14.57 233 2,141,225 10.88
35–39 116 1,162,755 9.98 272 1,209,146 22.5 388 2,371,901 16.36
40–44 109 1,251,252 8.71 282 1,302,072 21.66 391 2,553,324 15.31
45–49 124 1,215,787 10.2 290 1,260,590 23.01 414 2,476,377 16.72
50–54 116 1,156,919 10.03 244 1,194,131 20.43 360 2,351,050 15.31
55–59 133 1,158,074 11.48 192 1,192,054 16.11 325 2,350,128 13.83
60–64 98 1,088,416 9 155 1,123,714 13.79 253 2,212,130 11.44
65–69 86 918,417 9.36 120 966,922 12.41 206 1,885,339 10.93
70–74 76 737,121 10.31 94 826,237 11.38 170 1,563,358 10.87
75–79 49 567,655 8.63 83 715,409 11.6 132 1,283,064 10.29
80–84 44 378,833 11.61 47 577,891 8.13 91 956,724 9.51
85+ 99 250,076 39.59 142 569,334 24.94 241 819,410 29.41
** Per 100,000 population
doi:10.1371/journal.pone.0155181.t001
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figures are standardized to the age-distribution of the 1976 European population. The mean
age at first hospital admission for males was 52.95 (SD: 19.94) years and 50.47 (SD: 18.32) for
women. As expected, MS incidence in ages 0 to 10 for both sexes is low. In males, there is an
increase starting around age 30 and around age 25 for females. For both sexes, the highest inci-
dence is at age-group 85 and above, but this could be due to the aggregation of many ages or
late diagnosis. The disease onset is likely to have occurred much earlier—we address this matter
in the limitations section. See Table 1 for the sex-specific and combined MS incidence esti-
mates. The distribution of cases and sunshine levels by LSOA (Fig 1).
Month-by-month chi-square tests showed a 21 percent higher number of MS births in April
(Observed to Expected Ratio: 1.21 (95% CI: 1.08–1.36)) as compared with the general popula-
tion (χ2 = 10.99, df = 1, p< .001). No other month had birth numbers that differed signifi-
cantly from expected (Table 2). The regression model for the count of MS cases by LSOA
showed that MS incidence decreased by 25 percent for each additional hour of sunshine per
day. For each additional latitude north of Aberystwyth, MS incidence increased by 37 percent.
There was a significant Coast × Longitude interaction indicating that easterly coastal areas in
Fig 1. Average annual incidence of MS (2002 to 2013) and Average Sunshine Hours per day in Wales, UK. Left panel: Incidence by LSOA. Right
panel: Sunshine hours per day from 1961–1990. Inset: Wales location within the UK.
doi:10.1371/journal.pone.0155181.g001
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Wales had lower MS incidence. For those living west of Carmarthenshire, living in a coastal
area did not make a difference in incidence rates (Table 3 and Fig 2).
Discussion
The main finding of this study is that Wales has an incidence rate of MS similar to that of Scot-
land. Higher daily sunshine hours was inversely associated with MS. Our results also supported
the latitude hypothesis, with the number of cases increasing as one moves north within Wales
itself. Residing in a coastal area was associated with lower MS incidence in more easterly areas.
There was a higher than expected number of MS births for April, suggesting that maternal sun-
shine exposure during pregnancy is involved.
In comparison to other studies, our all-Wales age-standardized incidence rates are consider-
ably higher than in previous UK studies [4, 33]where the estimates for females ranged from 7.2
to 11.52 and for males 3.1 to 4.84 per year per 105 population [3, 34]. A previous study of aver-
age annual MS incidence in South East Wales during 1985 to 2005 reported 1.65 and 4.66 for
males and females, respectively per 105 population. Various areas in Scotland have reported
combined sexes incidence rates of 5.7 in Glasgow, 7.2 in Tayside, 10.1 in the Border Region,
and 12.2 in the Lothian Region per year per 105 population [34–36]. It is striking that our sex-
specific incidence rates for Wales are within the same range as the estimates for Scotland. Our
incidence rates for Wales are slightly higher than for those in France where the figures are 7.5
for males and 10.4 for females [37]. Although the latter is consistent with the latitude gradient,
the similarity of the incidence rates in Wales and Scotland is quite unexpected.
Table 2. Month of birth from 1938 to 2005, General Population vs People with MS inWales.
Month All England and Wales births Births of People with
MS in Wales
Observed-to-Expected Ratio (95% CI) Chi-square P
Observed Expected
January 3,938,576 238 244 0.98 (0.86–1.11) 0.15 0.70
February 3,693,432 221 229 0.97 (0.84–1.10) 0.28 0.60
March 4,162,616 230 258 0.89 (0.78–1.01) 3.04 0.08
April 3,973,205 298 246 1.21 (1.08–1.36) 10.99 <.001
May 4,146,640 268 257 1.04 (0.92–1.18) 0.47 0.49
June 3,969,042 242 246 0.98 (0.86–1.12) 0.07 0.80
July 4,062,277 254 252 1.01 (0.89–1.14) 0.02 0.90
August 3,953,452 244 245 1.00 (0.88–1.13) 0.00 0.95
September 3,942,578 265 245 1.08 (0.96–1.22) 1.63 0.20
October 3,882,108 228 241 0.95 (0.83–1.08) 0.70 0.40
November 3,664,537 220 227 0.97 (0.85–1.11) 0.22 0.64
December 3,802,065 219 236 0.93 (0.81–1.06) 1.22 0.27
doi:10.1371/journal.pone.0155181.t002
Table 3. Quasi-poisson regression model of MS births by LSOA Characteristic.
Explanatory Variable Incidence Rate Ratio 95% CI
Average daily sunshine hours 0.75 0.63–0.91
Latitudes north of Aberystwyth 1.37 1.30–1.45
Longitudes east of Carmarthenshire 0.74 0.68–0.81
Coastal area (yes/no) 0.94 0.83–1.05
Longitudes east of Carmartenshire x Coastal Area 0.61 0.49–0.77
doi:10.1371/journal.pone.0155181.t003
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That the highest numbers of MS cases for both males and females occurred in the 85 and
over age group is surprising. This could be an artefact of the higher hospital visits in this sub-
group and/or collapsing more than five age groups in the category. One possibility is that
although MS was pre-existing in some of these older people, a diagnosis was made only upon
visiting the hospital—which tends to be more likely at older ages. The change in UK guidelines
in 2003 may have contributed to the high MS incidence in the 85 and above age group. The
other possibility is that there truly is a spike in MS incidence in these ages during 1990 to 2010
[3]. Unfortunately, we cannot determine which of the two possibilities is true.
The finding that MS cases are 20 percent higher in April has been previously reported in
Scotland, the UK as a whole, Italy, and Finland [11, 38]. However, contrary to previous results,
we neither found higher births in May or lower births in October or November[10, 39]. Dob-
son and colleagues proposed that month of birth reflects the availability of vitamin D in the
prenatal environment [11]. Vitamin D helps tune the foetal immune system by suppressing
inflammatory cytokines and promoting self-tolerance [7]. MS represents a disturbance of the
immune system in which T-cells attack myelin protein [40].The winter months in the UK are
from December to February, so those born in April would have been in their 5th to 7th months
of gestation. It would be important to further examine if maternal vitamin D sufficiency is
more critical in certain months of gestation.
Above 52 degrees latitude (roughly, Cambridge or Aberystwyth, UK), there is insufficient
UV light for vitamin D synthesis during the winter months [29]. In this regard, proposals have
been put forward for dietary supplementation [11]. The ecological nature of our study design
makes us unable to interpret the link of more easterly coastal residence with lower MS births. A
future study, with measures of individual fish consumption, would be able to comment on this
Fig 2. Coast × Longitude interaction in the incidence of multiple sclerosis by LSOA in Wales, UK.Rug
plot on the x-axis indicates the distribution of coastal and non-coastal areas.
doi:10.1371/journal.pone.0155181.g002
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finding. The evidence regarding dietary supplementation is inconsistent. Eating fish three
times a week or more in childhood and adolescence was found protective for MS [30]. Munger
and colleagues [41]pooled two large prospective cohorts of nurses (n> 150,000). They found
that>400 IU of vitamin D from supplements was protective for MS. In Canada, the association
of serum 25OHD levels and dietary vitamin D intake (from milk and multivitamins) was stud-
ied [42]. No significant association was found. More studies are required as to whether the
risks of fortifying food with vitamin D are outweighed by its benefits. Thus far, small clinical
studies have shown that vitamin D supplementation is safe and these results support large ran-
domized trials [6].
As with all studies, the present one is subject to several limitations. First and foremost, the
present study is ecological in design and did not include individual level variables other than
week of birth and gender. While coastal residence could serve as population-level proxy for sea-
food consumption, the lack of person-level dietary information precludes an interpretation.
Secondly, the present study relied on a hospital-based register. This means that persons with
MS who do not visit the hospital go undetected. We have chosen to err on the side of underesti-
mation by not using the general practice register for two reasons. UK clinical guidelines since
2003 require that patients suspected of having MS be referred to a specialist neurologist on the
basis of CNS lesions [29]. Furthermore, a previous study using the general practice database
noted that the diagnosis of multiple sclerosis in the General Practice Research Database has not
been validated [3]. In analysing MS months of birth, we used the combined England and Wales
births from 1938 to 2005. This could affect our estimate of April births if the birth pattern dif-
fered between England and Wales. The main strengths of our study are data from a hospital-
based administrative register with 100 percent coverage of hospital visits in Wales and data on
sunshine hours at the small area level.
Conclusion
This is the first study of MS incidence covering all of Wales and we found an incidence rate
comparable to that of Scotland. The variation in incidence is related to geographical factors
that probably represent levels of vitamin D.
Supporting Information
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